Literature DB >> 23404294

Treatment guidelines for HCV genotype 1: mono for low, triple for high, and dual for 'middle'?

Masaru Enomoto, Akihiro Tamori, Sawako Kobayashi, Shuji Iwai, Hiroyasu Morikawa, Norifumi Kawada.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23404294     DOI： 10.1007/s00535-013-0759-4

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  6 in total

1.  Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan.

Authors:  Hiromitsu Kumada; Joji Toyota; Takeshi Okanoue; Kazuaki Chayama; Hirohito Tsubouchi; Norio Hayashi
Journal:  J Hepatol       Date:  2011-08-07       Impact factor: 25.083

2.  Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan.

Authors:  Hiromitsu Kumada; Takeshi Okanoue; Morikazu Onji; Hisataka Moriwaki; Namiki Izumi; Eiji Tanaka; Kazuaki Chayama; Shotaro Sakisaka; Tetsuo Takehara; Makoto Oketani; Fumitaka Suzuki; Joji Toyota; Hideyuki Nomura; Kentaro Yoshioka; Masataka Seike; Hiroshi Yotsuyanagi; Yoshiyuki Ueno
Journal:  Hepatol Res       Date:  2010-01       Impact factor: 4.288

3.  Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.

Authors:  Yasuhito Tanaka; Nao Nishida; Masaya Sugiyama; Masayuki Kurosaki; Kentaro Matsuura; Naoya Sakamoto; Mina Nakagawa; Masaaki Korenaga; Keisuke Hino; Shuhei Hige; Yoshito Ito; Eiji Mita; Eiji Tanaka; Satoshi Mochida; Yoshikazu Murawaki; Masao Honda; Akito Sakai; Yoichi Hiasa; Shuhei Nishiguchi; Asako Koike; Isao Sakaida; Masatoshi Imamura; Kiyoaki Ito; Koji Yano; Naohiko Masaki; Fuminaka Sugauchi; Namiki Izumi; Katsushi Tokunaga; Masashi Mizokami
Journal:  Nat Genet       Date:  2009-09-13       Impact factor: 38.330

4.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

5.  An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases.

Authors:  Marc G Ghany; David R Nelson; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2011-09-26       Impact factor: 17.425

Review 6.  Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines.

Authors:  Kazuaki Chayama; C Nelson Hayes; Waka Ohishi; Yoshiiku Kawakami
Journal:  J Gastroenterol       Date:  2012-11-28       Impact factor: 7.527
  6 in total
  1 in total

1.  MHC class I-related chain B gene polymorphism is associated with virological response to pegylated interferon plus ribavirin therapy in patients with chronic hepatitis C infection.

Authors:  Ayumi Asada; Makoto Shioya; Rie Osaki; Takashi Nishimura; Takayuki Takeuchi; Yoshiaki Okumura; Akira Andoh
Journal:  Biomed Rep       Date:  2014-12-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.